Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × mogamulizumab × Clear all

Phase

Status

Completed 12 Active not recruiting 3 Terminated 1 Recruiting 1 Not yet recruiting 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mycosis Fungoides 1

Interventions

Injections 37 Carboplatin 29 Capecitabine 25 Oxaliplatin 24 Paclitaxel 22 Docetaxel 22 Cisplatin 21 Bevacizumab 21 pembrolizumab 19 Pemetrexed 17 Gemcitabine 17 Fluorouracil 12 Cyclophosphamide 12 Irinotecan 11 Leucovorin 9 tislelizumab 8 Nivolumab 8 osimertinib 7 fludarabine 7 Trastuzumab 7 regorafenib 6 lenvatinib 6 Doxorubicin 6 130-nm albumin-bound paclitaxel 6 toripalimab 5 Topotecan 5 Temozolomide 5 Rituximab 5 Platinum 5 Drug Therapy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529405 2026-04-14

CurbMF

Virogen Biotechnology Inc.

Phase 2 Not yet recruiting

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon ⚡